Rosenblatt Palantir · PLTR

Rosenblatt Keeps Buy on Palantir, $260 Price Target

Analyst: John McPeake 1 min read Reproduced verbatim
Rating
Buy
Unchanged
Target
$260
Unchanged
Upside
+53%
PLTR at $169 today
Rosenblatt and Palantir logos

What the analyst said

Rosenblatt analyst John McPeake reiterated a Buy rating and $260 price target on Palantir (NASDAQ: PLTR).

“This was a remarkable quarter for Palantir, with companywide acceleration of 300bps Q/Q to +96% Y/Y top line, adjusted operating income +138% Y/Y, and FCF +139% Y/Y to 52% of revenues.

The company’s AI sovereignty push (where enterprises fully control their AI) is only one quarter old and this has resulted in a flurry of shorter duration enterprise deals, as reflected in decelerated TCV (total contract value) growth in for U.S. commercial of +11% Y/Y.

We think this divergence with the 148% U.S. commercial revenue growth is causing unwarranted concern, as we discuss in detail below.

Going forward we expect the duration and size of these deals to increase to historic levels and TCV to normalize back to revenue growth.

We think the large TAM, competitive moat, and ongoing operating leverage continue to make PLTR an attractive investment.

We are raising our 2026 estimates, but keeping our Street high 2027 and beyond numbers materially unchanged. Our $260 price target is 60x EPS one year out and 46% upside from current levels.

Reiterating Buy and $260 target on Palantir.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

PLTR trades at $169. The 17 analysts who set a target in the last 3 months range from $130 to $265, with a median of $250. This $260 target is 4% above the median.

12-month window: day 0 of 365, closes on November 3, 2027.

Track record

This callOpen: PLTR has not reached $260 yet. This 12-month target is scored on October 27, 2027. Same target as this firm’s October 27, 2026 note, so it is scored there.

Firm track recordRosenblatt: 58% of its 19 targets at least a year old were reached within 12 months (#25 of 26 firms). Accuracy ranking →

Rosenblatt on Palantir

Rosenblatt price targets on Palantir

8 calls from February 26, 2026 to November 3, 2026. The target went from $150 to $260 (+73%). The rating stayed Buy.

Rosenblatt targetPLTR share price
  1. November 3, 2026 This noteKept the $260 targetBuy$260
  2. October 27, 2026Target raised from $225 (+16%)Buy$260
  3. September 23, 2026Kept the $225 targetBuy$225
  4. June 5, 2026Kept the $225 targetBuy$225
  5. May 20, 2026Kept the $225 targetBuy$225
  6. May 5, 2026Target raised from $200 (+13%)Buy$225
  7. March 3, 2026Target raised from $150 (+33%)Buy$200
  8. February 26, 2026Earliest call shownBuy$150
Share

Other analysts on Palantir

Goldman SachsBuy Kept rating and price target Nov 3 $235maintained BairdBuy Kept rating and price target Nov 3 $250maintained UBSBuy Kept rating and price target Nov 3 $250maintained Piper SandlerBuy Raised price target +2%, kept rating Nov 3 $235from $231 RBC CapitalSell Raised price target +44%, kept rating Nov 3 $130from $90
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.